Portola Initiates Phase II Clinical Program In Heart Attack Patients With Its Novel Antiplatelet Agent, PRT060128

Portola Pharmaceuticals, Inc. announced the initiation of a Phase II clinical trial of the intravenous (IV) formulation of PRT060128 in patients experiencing an ST-segment elevation myocardial infarction (STEMI), or heart attack. The trial, known as ERASE-MI, will enroll approximately 200 patients across North America and Europe. PRT060128 is an antiplatelet compound that is the only reversible IV and oral ADP receptor antagonist in clinical development. [click link for full article]

More: continued here

Comments are closed.



My Pills Store - Buy Online: My Pills store
My RX Pharmacy - Buy Online: My RX pharmacy
Order Fioricet Pills - Buy Drugs: Order Fioricet pills
Order RX Drugs - Buy Online: Order RX Drugs from pharmacy online.
Rx Buy - Order Drugs: Rx buy
Rx Free - : Rx Free
Tramadol Tabs - Tramadol Tabs: Tramadol tablets
Yo Durgs - Buy Your Pills: Getting drugs online gives you many advantages like privacy, saving money and saving TIME
Your Health Rx - : Your Health Rx
Medicine Value - Medicine Value: Value the medicine advice
My super dtrug store - : My super dtrug store
Latest News...